Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma. - Wikidata - awgldk - TriplyDB

Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma.

Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma.

http://www.wikidata.org/entity/Q33370138

about

Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer NOX1 supports the metabolic remodeling of HepG2 cells Laser-capture microdissection impairs activity-based protein profiles for serine hydrolase in human lung adenocarcinoma Annexin A3 as a Prognostic Biomarker for Breast Cancer: A Retrospective Study.Primary cell cultures from human renal cortex and renal-cell carcinoma evidence a differential expression of two spliced isoforms of Annexin A3.2D-difference gel electrophoretic proteomic analysis of a cell culture model of alveolar rhabdomyosarcoma.A novel method for sample preparation of fresh lung cancer tissue for proteomics analysis by tumor cell enrichment and removal of blood contaminants.Hydrophobic Fractionation Enhances Novel Protein Detection by Mass Spectrometry in Triple Negative Breast Cancer.Hydrophobic Proteome Analysis of Triple Negative and Hormone-Receptor-Positive-Her2-Negative Breast Cancer by Mass Spectrometer.Comparative proteome analysis of human lung squamous carcinoma using two different methods: two-dimensional gel electrophoresis and iTRAQ analysis.Mass spectrometry-based proteomics: the road to lung cancer biomarker discovery.Proteomic analysis of whole human saliva detects enhanced expression of interleukin-1 receptor antagonist, thioredoxin and lipocalin-1 in cigarette smokers compared to non-smokers.S100A4 over-expression underlies lymph node metastasis and poor prognosis in colorectal cancer.Galectin-4, a novel predictor for lymph node metastasis in lung adenocarcinoma Aniline-induced nitrosative stress in rat spleen: proteomic identification of nitrated proteins.TIPE2 Inhibits Lung Cancer Growth Attributing to Promotion of Apoptosis by Regulating Some Apoptotic Molecules Expression.Proteome analysis of bronchoalveolar lavage in pulmonary langerhans cell histiocytosis Annexin A3 is a mammary marker and a potential neoplastic breast cell therapeutic target.Annexin A3 Is a Potential Predictor of Platinum Resistance in Epithelial Ovarian Cancer Patients in a Prospective Cohort ANXA3/JNK Signaling Promotes Self-Renewal and Tumor Growth, and Its Blockade Provides a Therapeutic Target for Hepatocellular Carcinoma.Identifying DCN and HSPD1 as Potential Biomarkers in Colon Cancer Using 2D-LC-MS/MS Combined with iTRAQ Technology.Label-free quantitative proteomics of CD133-positive liver cancer stem cells Protein expression of nucleophosmin, annexin A3 and nm23-H1 correlates with human nasopharyngeal carcinoma radioresistance in vivo.Secretion of annexin A3 from ovarian cancer cells and its association with platinum resistance in ovarian cancer patients.Challenges in cancer research and multifaceted approaches for cancer biomarker quest.Biomarkers of lung-related diseases: current knowledge by proteomic approaches.Overexpression of ANXA3 is an independent prognostic indicator in gastric cancer and its depletion suppresses cell proliferation and tumor growth.Cancer: a proteomic disease.Proteomic research progress in lymphatic metastases of cancers.The role of annexin A3 playing in cancers.Proteomic biomarkers in lung cancer.Proteomics in investigation of cancer metastasis: functional and clinical consequences and methodological challenges.Annexin A4 is a promising therapeutic target for the treatment of platinum-resistant cancers.Epidemiologic design and analysis for proteomic studies: a primer on -omic technologies.Annexin A3 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma.Proteomic Identification of an Upregulated Isoform of Annexin A3 in the Spinal Cords of Rats in a Neuropathic Pain Model Prognostic value of Annexin A3 in human colorectal cancer and its correlation with hypoxia-inducible factor-1α Clinical significance of S100A2 expression in gastric cancer.Application of a co‑expression network for the analysis of aggressive and non‑aggressive breast cancer cell lines to predict the clinical outcome of patients.Downregulation of annexin A3 inhibits tumor metastasis and decreases drug resistance in breast cancer.

P2860

Q28393146-9333712F-ECC1-4438-9BFD-2282E15093B5 Q28544991-8476CB5A-E4F1-46EA-B517-98CB5E8C0E7F Q33548332-E1706997-2AC0-4222-9844-30B613A1D797 Q33608061-E9750CC2-4A85-48ED-9C1C-F9426CABBC19 Q33745126-245EC608-7C9F-4E8B-BB15-A6A24F2153C6 Q33756595-756F1C63-5DFA-4141-9F33-6B5CD00E9E11 Q33761618-78B6CB4C-5CE1-49CC-8051-DF8436AAC1AF Q33951586-BA09A80B-A25C-485E-A48B-F639E1C17565 Q34117974-2C19489D-10F8-49AD-BDF6-782E1A3AC503 Q34195208-D894F896-0A1A-44ED-8745-343DDADFAB90 Q34350615-D9121186-B7A3-4421-8FC8-BC0528A395C7 Q34396094-162A3FA1-3F90-4802-91B6-5B26CE89C80F Q34469540-E6A07D5F-7C9E-4667-96D0-E58E6C32C914 Q35067654-A01CDEA2-F8CD-4DB7-B543-2021B4497493 Q35538384-0501824B-56F6-47F8-B9BE-B671C453EF4B Q35577788-2B79BC0D-CF6B-43E9-A0BC-71AA89D254B3 Q35619235-F70D6B5A-12F8-4416-AF83-A3E762638AB2 Q35669421-0BBC6500-769C-44EE-93E5-A04BA5912EAE Q35739552-10E6AA07-325D-4B59-9B08-506D6207F179 Q36200984-E66F136C-F805-4A14-AD9F-633F51E99BD1 Q36297724-939007C2-1A58-4595-BD25-EEB404C86959 Q36621286-6FB77721-7FAE-4EF0-8351-8CF0AC065825 Q37002731-DDC91910-C3C4-4548-896D-5DF7F282CA03 Q37295775-AB596E39-1218-4D1B-8604-19DF0A32D2CA Q37425361-222370EE-8E04-4D0F-9726-57D9A21A965E Q37579765-E594BCAF-2663-4CA3-B78C-2951F3ACD343 Q37699354-CAB5232F-EA15-4ABF-89EA-D4CB0975D9F6 Q37860196-ABB88C4A-B71B-4B26-94AC-C9930EE66FDA Q37977415-2878A1B8-0FB2-4FBB-8D98-83A01BC80A72 Q38046543-6D85CC55-4D64-4844-BE6C-D9964F7BE928 Q38100750-30D22BFA-EF49-4F6D-AC42-B2F0F53F07D8 Q38165894-E0EEDFD4-0429-456B-B007-5BF07122C764 Q38183430-7E374532-3001-42EE-8799-77AEA42109DD Q38384848-37057307-1886-4D34-A7BF-E80A4009C75B Q39038718-F7C381E1-20C9-48C5-A2EA-2578C2F68C3C Q41454437-D29047DF-3A9A-4372-96B3-C50DA1E6FF7E Q42055572-8A008C79-95F7-48B9-BF83-9102C4328A48 Q46783208-AF1CC4DB-6026-4E26-9BFF-2FB3847CAE89 Q47637451-1D8DDE04-F6A3-4BF5-9C77-512D86546473 Q47837574-48648E8D-09E3-44A2-A8E7-DCADED40F8EE

P2860

Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma.

http://www.wikidata.org/entity/Q33370138

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Quantitative proteome analysis ...... marker in lung adenocarcinoma.

@ast

Quantitative proteome analysis ...... marker in lung adenocarcinoma.

@en

type

label

Quantitative proteome analysis ...... marker in lung adenocarcinoma.

@ast

Quantitative proteome analysis ...... marker in lung adenocarcinoma.

@en

prefLabel

Quantitative proteome analysis ...... marker in lung adenocarcinoma.

@ast

Quantitative proteome analysis ...... marker in lung adenocarcinoma.

@en

P1433

Q33370138-0C0C0EF5-D885-4E48-8F5D-61AF79DA4601

P1476

Q33370138-D94E86FE-2481-401A-A37B-C659B00F3E44

P2093

Q33370138-19764A60-9D21-43CC-B49F-5E876693A128

Q33370138-251C8299-3845-4AA5-B992-10BCBB592AC4

Q33370138-3324A77D-FBA9-4D64-9C61-3C6589BC5C2B

Q33370138-3C37E1F4-9F99-47A8-B548-8A53D8DEE7A0

Q33370138-41518ECF-D87E-4556-B58C-E69265BD9A25

Q33370138-4989007E-F01B-4B83-852F-766574314985

Q33370138-691FFA89-0A6E-40F3-AA89-C58F3CCB1F7B

Q33370138-A135C38D-B883-4F33-8331-E88122162460

Q33370138-B2FFC17A-A988-40ED-BCD6-B931F6BB3831

Q33370138-EBBC2AD4-8CB9-4674-BD40-C6C074EABF3B

P2860

Q33370138-0335BF80-7053-4F9F-A8CF-4EA5450DDA28

Q33370138-1E83EA99-44F3-43E6-AACE-A93F05E788D6

Q33370138-76766731-BD86-4551-AF60-2EECB944F4F7

Q33370138-BDA6E65F-06CC-4984-9F83-C9D5C9518B80

P304

Q33370138-85F08054-9549-4586-B5CA-F67ED99E9207

P31

Q33370138-227BA60F-2C88-4AC6-90BC-AFE318BE87D7

P356

Q33370138-A582ACB3-1780-4195-A0CA-87F86C3A6837

P433

Q33370138-03F5C387-B0EB-411F-A78D-705AF457B672

P478

Q33370138-24B9DF7D-427E-41A5-AFB6-DC49A12552C0

P577

Q33370138-8266F02B-6904-40B2-BE96-F0D2893CF15E

P698

Q33370138-28BB3425-75D4-41F5-8FD8-AED22B5305D5

P921

Q33370138-2A85C4C8-F810-4BD6-A299-5F9AD2835BEC

Q33370138-6FA52E3B-EDB5-4F54-99B1-D0978520975E

P356

P1433

The Journal of Pathology

P1476

Quantitative proteome analysis ...... marker in lung adenocarcinoma.

@en

P2093

C Li

http://www.w3.org/2001/XMLSchema#string

F Li

http://www.w3.org/2001/XMLSchema#string

H X Yao

http://www.w3.org/2001/XMLSchema#string

H Yi

http://www.w3.org/2001/XMLSchema#string

M X Li

http://www.w3.org/2001/XMLSchema#string

M Y Li

http://www.w3.org/2001/XMLSchema#string

P F Zhang

http://www.w3.org/2001/XMLSchema#string

Y F Liu

http://www.w3.org/2001/XMLSchema#string

Y H Chen

http://www.w3.org/2001/XMLSchema#string

Z Q Xiao

http://www.w3.org/2001/XMLSchema#string

P2860

Annexins: from structure to function

Elevated expression of annexin II (lipocortin II, p36) in a multidrug resistant small cell lung cancer cell line.

Up-regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation

Immunohistochemical analysis of cathepsin B expression in human lung adenocarcinoma: the role in cancer progression.

P304

54-64

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PATH.2429

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

217

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18798225

http://www.w3.org/2001/XMLSchema#string

P921